Vaccinations
Children
Children 2–10 years of age who are at high risk for meningococcal disease such as certain chronic medical conditions and travel to or reside in countries with hyperendemic or epidemic meningococcal disease should receive primary immunization. Although safety and efficacy of the vaccine have not been established in children younger than 2 years of age and under outbreak control, the unconjugated vaccine can be considered. Adolescents
Primary immunization against meningococcal disease with meningitis A, C, Y and W-135 vaccines is recommended for all young adolescents at 11–12 years of age and all unvaccinated older adolescents at 15 years of age. Although conjugate vaccines are the preferred meningococcal vaccine in adolescents 11 years of age or older, polysaccharide vaccines are an acceptable alternative if the conjugated vaccine is unavailable. Adults
Primary immunization with meningitis A, C, Y and W-135 vaccines is recommended for college students who plan to live in dormitories, although the risk for meningococcal disease for college students 18–24 years of age is similar to that of the general population of similar age.Routine primary immunization against meningococcal disease is recommended for most adults living in areas where meningococcal disease is endemic or who are planning to travel to such areas. Although conjugate vaccines are the preferred meningococcal vaccine in adults 55 years of age or younger, polysaccharide vaccines are an acceptable alternative for adults in this age group if the conjugated vaccine is unavailable.
Benzamycin is a topical gel containing of 5% benzoyl peroxide and 3% erythromycin. Its main usage is to fight acne. Benzamycin is a prescription medication.Side effects include dry skin, stinging, redness, and itchy rash (urticaria), with recommended usage is 2 times per day, once in the morning and once in the evening, or as prescribed by a doctor. The affected area should be washed with soap and warm water, rinsed, and gently dried before applying the gel. Using an oil-free face moisturizer in conjunction with Benzamycin is recommended. On March 30, 2004, a generic form of Benzamycin was released by pharmaceutical company Atrix Laboratories. References
External links
"Atrix Laboratories, Inc. (ATRX) Receives FDA Approval For Erythromycin/Benzoyl Peroxide", Biospace.com, 10/19/2005